SEM · Select Medical Holdings Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.42B | - | $1.36B | $1.34B | $1.35B | - | $1.76B | $1.76B | $1.79B | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $39.38M | - | $40.05M | $35.66M | $33.01M | - | $47.35M | $49.88M | $48.45M | - |
| Total Operating Expenses | $1.32B | - | $1.29B | $1.25B | $1.24B | - | $1.62B | $1.60B | $1.60B | - |
| D&A | $37.67M | - | - | - | $34.81M | - | $50.14M | $53.94M | $54.07M | - |
| Operating Income | $98.42M | - | $72.96M | $86.53M | $112.75M | - | $141.13M | $157.80M | $193.97M | - |
| Interest Expense | $28.34M | - | $30.02M | $29.98M | $40.68M | - | $50.27M | $37.11M | $50.76M | - |
| Income Tax | $18.32M | - | $11.75M | $12.29M | $21.45M | - | $26.81M | $32.24M | $36.46M | - |
| Net Income | $43.99M | - | $28.79M | $40.57M | $56.68M | - | $55.63M | $77.56M | $96.90M | - |
| EPS - Basic | $0.35 | - | $0.23 | $0.32 | $0.44 | - | $0.23 | $0.32 | $0.40 | - |
| EPS - Diluted | $0.35 | - | $0.23 | $0.32 | $0.44 | - | $0.23 | $0.32 | $0.40 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25.68M | $26.52M | $60.05M | $52.35M | $53.21M | $59.69M | $191.47M | $111.16M | $92.62M | $84.01M |
| Accounts Receivable | $949.48M | $864.21M | $825.81M | $909.46M | $908.18M | $821.38M | $1.06B | $1.08B | $1.13B | $940.34M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $166.47M | $157.06M | $167.10M | $163.26M | $158.54M | $142.16M | $170.71M | $160.13M | $163.55M | $174.31M |
| Current Assets | $1.11B | $1.03B | $1.02B | $1.08B | $1.09B | $1.02B | $1.40B | $1.37B | $1.44B | $1.26B |
| Total Assets | $6.04B | $5.85B | $5.69B | $5.74B | $5.70B | $5.61B | $8.00B | $7.88B | $7.86B | $7.69B |
| Current Liabilities | $970.37M | $984.49M | $939.58M | $938.99M | $944.80M | $977.65M | $1.25B | $1.26B | $1.18B | $1.25B |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $3.94B | $3.82B | $3.67B | $3.74B | $3.65B | $3.61B | $5.70B | $6.14B | $6.19B | $6.12B |
| Stockholders' Equity | $1.76B | $1.71B | $1.69B | $1.67B | $1.72B | $1.68B | $1.92B | $1.42B | $1.37B | $1.29B |
| Retained Earnings | $872.22M | $837.02M | $824.81M | $804.73M | $813.50M | $770.15M | $1.06B | $891.40M | $830.82M | $751.86M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $37.86M | - | - | - | ($3.46M) | - | - | - | ($66.69M) | - |
| Investing Cash Flow | ($56.66M) | - | - | - | ($52.31M) | - | - | - | ($57.66M) | - |
| Financing Cash Flow | $17.95M | - | - | - | $49.29M | - | - | - | $132.96M | - |
| CapEx | $58.90M | - | - | - | $52.34M | - | $50.68M | $55.55M | $52.52M | - |
| Free Cash Flow | ($21.04M) | - | - | - | ($55.80M) | - | - | - | ($119.21M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 6.9% | - | 5.4% | 6.5% | 8.3% | - | 8.0% | 9.0% | 10.8% | - |
| EBITDA margin | 9.6% | - | - | - | 10.9% | - | 10.9% | 12.0% | 13.9% | - |
| Net margin | 3.1% | - | 2.1% | 3.0% | 4.2% | - | 3.2% | 4.4% | 5.4% | - |
| Free cash flow margin | -1.5% | - | - | - | -4.1% | - | - | - | -6.7% | - |
| FCF / Net income | -0.48 | - | - | - | -0.98 | - | - | - | -1.23 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 2.8% | - | 2.9% | 2.7% | 2.4% | - | 2.7% | 2.8% | 2.7% | - |
| Effective tax rate | 29.4% | - | 29.0% | 23.3% | 27.5% | - | 32.5% | 29.4% | 27.3% | - |
| Return on assets | 0.7% | - | 0.5% | 0.7% | 1.0% | - | 0.7% | 1.0% | 1.2% | - |
| Return on equity | 2.5% | - | 1.7% | 2.4% | 3.3% | - | 2.9% | 5.5% | 7.1% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.15 | 1.04 | 1.09 | 1.15 | 1.16 | 1.04 | 1.13 | 1.09 | 1.22 | 1.01 |
| Quick ratio | 1.15 | 1.04 | 1.09 | 1.15 | 1.16 | 1.04 | 1.13 | 1.09 | 1.22 | 1.01 |
| Cash ratio | 0.03 | 0.03 | 0.06 | 0.06 | 0.06 | 0.06 | 0.15 | 0.09 | 0.08 | 0.07 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 3.5x | - | 2.4x | 2.9x | 2.8x | - | 2.8x | 4.3x | 3.8x | - |
| Equity multiplier | 3.44 | 3.43 | 3.37 | 3.44 | 3.31 | 3.34 | 4.18 | 5.56 | 5.75 | 5.97 |
| Liabilities / Assets | 0.65 | 0.65 | 0.64 | 0.65 | 0.64 | 0.64 | 0.71 | 0.78 | 0.79 | 0.80 |
| Efficiency | ||||||||||
| Asset turnover | 0.24 | - | 0.24 | 0.23 | 0.24 | - | 0.22 | 0.22 | 0.23 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 244d | - | 221d | 248d | 245d | - | 220d | 224d | 232d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 46.5x | - | 55.8x | 47.4x | 38.0x | - | 81.1x | 58.4x | 40.2x | - |
| P / B | 1.1x | - | 0.9x | 1.1x | 1.2x | - | 1.2x | 1.7x | 1.5x | - |
| P / S | 1.4x | - | 1.1x | 1.4x | 1.6x | - | 1.3x | 1.3x | 1.1x | - |
| EV / EBITDA | 14.3x | - | - | - | 13.9x | - | 11.2x | 10.5x | 7.7x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 5.0% | - | -22.6% | -23.9% | -24.4% | - | 5.7% | 5.1% | 7.4% | - |
| Revenue CAGR (3y) | -5.1% | - | -4.5% | -5.4% | -5.4% | - | 4.7% | 4.0% | 5.0% | - |
| Revenue CAGR (5y) | -1.7% | - | -0.9% | 1.7% | -0.9% | - | 4.8% | 5.3% | 6.2% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -12.7% | - | -48.3% | -45.2% | -41.9% | - | 8.6% | -0.9% | 28.1% | - |
| Net income growth (YoY) | -22.4% | - | -48.2% | -47.7% | -41.5% | - | 15.5% | -0.9% | 36.9% | - |
| EPS growth (YoY) | -20.5% | - | -0.7% | -1.0% | 8.9% | - | -39.0% | -47.0% | -27.8% | - |
| EPS CAGR (3y) | -14.5% | - | 3.1% | -9.4% | -18.7% | - | -25.9% | -35.8% | - | - |
| EPS CAGR (5y) | - | - | -16.6% | -3.9% | 1.9% | - | 0.1% | -0.4% | 6.1% | - |
| FCF growth (YoY) | 62.3% | - | - | - | 53.2% | - | - | - | -1501.2% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 2.1% | 1.4% | -11.8% | 17.7% | 25.8% | 30.5% | 51.1% | 13.7% | 16.8% | 14.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$8.82B totalCritical Illness Recovery Hospital$2.48B · 28.1%
Critical Illness Recovery Hospitals$2.48B · 28.1%
Rehabilitation Hospital$1.29B · 14.6%
Rehabilitation Hospitals$1.29B · 14.6%
Outpatient Rehabilitation$1.28B · 14.6%
Product / service
$4.95B totalHealth Care Patient Service$2.47B · 50.0%
Health Care Patient Service Non Medicare$1.69B · 34.0%
Health Care Patient Service Medicare$788.43M · 15.9%
Service Other$4.00M · 0.1%
Peer comparison
Same SIC group: Services-Hospitals
Comparing SELECT MEDICAL HOLDINGS CORP against the 3 most active filers in the same SIC group.
Dividends
$0.25/share trailing 12 months · -3.3% YoY
| Ex-date | Per share |
|---|---|
| May 14, 2026 | $0.0630 |
| Mar 2, 2026 | $0.0630 |
| Nov 12, 2025 | $0.0630 |
| Aug 13, 2025 | $0.0630 |
| May 15, 2025 | $0.0630 |
| Mar 3, 2025 | $0.0630 |
| Nov 13, 2024 | $0.0673 |
| Aug 14, 2024 | $0.0673 |
| May 15, 2024 | $0.0673 |
| Feb 29, 2024 | $0.0673 |
| Nov 14, 2023 | $0.0673 |
| Aug 14, 2023 | $0.0673 |
| May 17, 2023 | $0.0673 |
| Mar 2, 2023 | $0.0673 |
| Nov 15, 2022 | $0.0673 |
| Aug 15, 2022 | $0.0673 |
| May 18, 2022 | $0.0673 |
| Mar 3, 2022 | $0.0673 |
| Nov 15, 2021 | $0.0673 |
| Aug 17, 2021 | $0.0673 |
| May 18, 2021 | $0.0673 |
| Mar 2, 2015 | $0.0539 |
| Nov 17, 2014 | $0.0539 |
| Aug 18, 2014 | $0.0539 |